Elevation Oncology Inc. Gains 77.19%
Wed, Apr 26, 2023 at 07:07 PM
Elevation Oncology Inc. (ELEV:NASDAQ) shot up at $3.03, a gain of 77.2%. On Wed, Apr 26, 2023, ELEV:NASDAQ hit a New 2-Week High of $3.03. The stock got featured on our News Catalysts scanner on Wed, Apr 26, 2023 at 05:41 PM in the 'BIOTECH' category. From Wed, Apr 12, 2023, the stock recorded 50.00% Up Days and 54.55% Green Days
About Elevation Oncology Inc. (ELEV:NASDAQ)
Elevation Oncology Inc is an oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically defined patient populations.
Top 10 Gainers:
- Elevation Oncology Inc. (ELEV:NASDAQ), 77.19%
- Etao International Co. Ltd. (ETAO:NASDAQ), 57.33%
- SAI.TECH Global Corp Cl A Ord (SAI:NASDAQ), 34.05%
- Euda Health Holdings Ltd Ord Shs (EUDA:NASDAQ), 34.01%
- Panbela Therapeutics Inc. (PBLA:NASDAQ), 33.33%
- Intuitive Machs Inc Cl A (LUNR:NASDAQ), 32.28%
- Beasley Broadcast Group, Inc. (BBGI:NASDAQ), 26.56%
- TDH Holdings, Inc. (PETZ:NASDAQ), 25.77%
- VYNE Therapeutics Inc. (VYNE:NASDAQ), 25.28%
- VCI Global Limited (VCIG:NASDAQ), 24.74%